Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account

vaccines News

  + XML/RSS  



By Simon Campbell
The CBCD has learned that Dr. Hanan Polansky as well as his discovery of Microcompetition with Foreign DNA were recently mentioned during an interview with Curt Linderman Sr. on Alex Jones’s “Prison Planet”.

By Physicians' Alliance of America
GlaxoSmithKline is the world's third largest pharmaceutical company and specializes in the production of treatments and vaccines for major disease areas including asthma, virus control, infections, mental health, diabetes and digestive conditions.

By Physicians' Alliance of America
Learn more about Sanofi Pasteur and some of their most popular vaccines including Fluzone, Pentacel and Menactra just to name a few.

By Frost & Sullivan
Targeted Therapies Offer Hope in the Face of Low Survival Rates and Increasing Incidence

By SMi Group
Building on the continual success of both our European and Asia Pacific events, this year's agenda will provide an unparalled opportunity for debate and problem solving of key challenges currently facing the parenteral market.

By GTC Conference
Leslie J. Williams, President and CEO at ImmusanT will give a presentation at the Immunotherapeutics Partnering and Deal-making conference (Jan 30-31, 2012 in San Diego, CA)

By GeoVax Labs
Researchers who work on HIV vaccines face a major challenge: convincing members of at-risk communities to volunteer for these trials.

By krishna sharma
A New Report from IMARC Group expects the growth of the biosimilar market to expand the demand of cold chain logistic services in the coming years.

By Applewood Retirement Residence
As we travel over the holiday season to vist friends and family, or to escape from the cold weather, here are some tips to ensure a safe and enjoyable.trip

By UBIFRANCE
In Cell Art, a biotechnology company specialising in the development of innovative vaccines and antibodies, has announced today the launch of a US$33.1 million research-and-development project — the RN Armor Vax Consortium.

By Arrowhead Publishers and Conferences
Arrowhead Publishers and Conferences’ World Cancer Immunotherapy Conference will take place January 25-26, 2012 in San Diego, California.

By BioStat Solutions, Inc.
BioStat Solutions, Inc. announces the appointment of Dr. Karen Woodward to serve as its Business Development Manager of the North East Region for the development of sales strategies to market BSSI's analytical abilities in pharmacogenomic studies.

By BioStat Solutions, Inc.
BioStat Solutions, Inc.,announces the appointment of Dr. Martina Fortin, to serve as its Business Development Manager for the Mid-Atlantic Region to market BSSI’s analytical abilities in molecular biomarker, medical device and vaccine studies.

By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.

By Simon Campbell
polyDNA, the makers of Gene-Eden-VIR, congratulates VBI Vaccines on its acquisition of Epixis, a biotechnology company that develops a new generation of Virus-Like Particle vaccines.

By Link China Pharma Solutions & ImmBio
Cambridge Based Vaccine Company ImmBio Joined-up With Sinopharm Vaccine Institute to Co-Develop Its T-BioVax Vaccine against TB Infection negotiated by Cambridge based biopharma consultancy company – Link China Pharma Solutions.

By Alain Lafeuillade
Although a cure is not yet within reach, experts are optimistic that they will unlock the secret to eradicating HIV with in the near future.

By Krishna Sharma
A new report from IMARC Group expects the strong growth of biopharmaceuticals and the launch of biosimilars to create huge opportunities for cold chain service providers

By Proven Health Ways, Inc
A family doctor in Wisconsin has developed an iPhone App that teaches health and expands and enhances the typical 7-minute office visit.

By GTC Conference
Dr. Jon Heinrichs, Director, Microbial Vaccines, Merck Research Laboratories, to deliver featured presentation at “9th Annual Vaccines Discovery and Development: All Things Considered” conference, to be held on Nov. 7-8, 2011 in Boston by GTC.

By GTC Conference
Dr. Joseph Joyce, Director, Vaccine Research, Merck Research Laboratories, to deliver featured speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA).

By Dave Ruede
Finding and buying Temperature@lert products has gotten a lot easier lately. That’s because we’ve crossed a significant milestone: we’ve signed up our 200th Reseller.

By Joe Walsh
‘Adult and Adolescent Vaccines Market to 2017 ’will hit $56.7 billion by 2017

By Krishna Sharma
Driven by a strong growth in the sales of vaccines, the demand for efficient cold chain packaging and transportation services is expected to grow robustly in the coming years.

By GBI Research
By 2017, the Global Vaccines Market is Expected to Generate More than Twice the Annual Revenue of 2010

By Krishna Sharma
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to reach values worth US$ 9.5 billion by 2016

By S Raju
Therapeutic vaccines promise a new wave of highly potent and highly specific therapeutic agents designed to work in harmony with patients’ own immune systems.

By Kalorama Information
There is a significant amount of vaccine clinical trials going on in Asia, according to healthcare market research publisher Kalorama Information's research report Asian Vaccine Markets.

By Compact Medical Guides LLC
Compact Medical Guides LLC launches site to educate the public regarding important and timely medical topics. Their goal is to provide inexpensive, easily accessible, easy to read health information via books, ebooks and applications.

By Jayme Porkolab - The Global Leaders
A lucky few will be able to hear four extraordinary people present their unique solutions to some of the issues facing the healthcare industry today at an exclusive lunch at the Yale Club in NYC June 7th coinciding with The World Innovation Forum.

By WoahMedia.com
New evidence suggests vaccinated children and adults suffer from significantly more ADHD, neurologic disorders, autism, asthma, allergies, respiratory infections and many other potentially serious illnesses, including cancer.

By Raju Pillai
The present Competitive Intelligence Report about Adenosine Receptor Agonists & Antagonists provides a competitor evaluation in the field

By Raju Pillai
The present Competitive Intelligence Report about Influenza Vaccines provides a competitor evaluation in the field of marketed and novel prophylactic vaccines.

By PRMG
Central Veterinary Associates is attempting to eradicate this dangerous disease that is deadly to both animals and humans.

By Global Research & Data Services
Today, Global Research & Data Services is going to publish several market analyses about the markets for vaccines in different European countries.

By Andreas Moritz
Bestselling author, Andreas Moritz, exposes the myth that vaccines prevent disease. Furthermore, he provides scientific evidence that vaccines not only fail to protect against disease, but actually, cause it or, at least, contribute to it.

By Fast Market Research
Fast Market Research recommends "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By CCM International Ltd
CCM will launch customer rewards and incentives for clients who purchase the products in 2011, as it is CCM’s 10th anniversary in 2011. As for the report, Future of Red Biotechnology in China, run-fast buyers could enjoy the rock bottom price

By PC MEDICS
A new book that claims we could abandon vaccines tomorrow, and be no worse off, is likely to spark intense debate.

By Dave Ruede
Site offers “How to” items, best practices, industry perspectives, and other information for those considering, installing, or using temperature monitoring systems for home, business, commercial properties, laboratories, and mobile applications.

By Kalorama Information
Even with achievements for some companies, numerous vaccines with apparently strong prospects have been hit by developmental delays and failures. Despite setbacks many developers are hopeful of a turnaround.

By Fast Market Research
New Healthcare market report from GlobalData: "Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review"

By Bharat Book
Bharatbook added a new report on "Global Vaccine Market Forecast to 2012" which gives the factors influencing the trends and developments in the vaccine market.

By innerbalancePR
New Publicity Company Offers Integrated Solutions and Experience To Promote Responsible Products and Services

By Arrowhead Publishers and Conferences
According to Arrowhead Publishers’ new publication, The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact, numerous challenges must be overcome to create optimal cancer vaccines on an economical scale.

By Larry Cook
Biomedical Treatment for Autism is a new website that shares video interviews of parents, researchers and medical professionals talking about alternative medical interventions that reverse the symptoms of Autism.

By Latinos in Social Media
Latinos in Social Media [LATISM] Applauds The Commitment Of The Center for Disease Control (CDC) To Provide This Valuable Information To Hispanics During This Flu Season

By sandlerresearch
GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Influenza Vaccines

By sandlerresearch
GlobalData, the industry analysis specialist, has released its new report, “Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Influenza Vaccines

By Kalorama Information
Although the therapeutic vaccine market has experienced a range of setbacks and disappointments, technological evolution should ultimately enable therapeutic vaccines to make similar commercial breakthroughs as monoclonal antibodies, notes Kalorama.



Page:



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share